Samaya Krishnan
Samaya Krishnan
Graduate Student, Department of Cellular and Structural Biology, University of Texas Health Science
Verified email at livemail.uthscsa.edu
Title
Cited by
Cited by
Year
KDM1 is a novel therapeutic target for the treatment of gliomas
GR Sareddy, BC Nair, SK Krishnan, VK Gonugunta, Q Zhang, T Suzuki, ...
Oncotarget 4 (1), 18, 2013
512013
Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response
BC Nair, SR Krishnan, GR Sareddy, M Mann, B Xu, M Natarajan, P Hasty, ...
Cell Death & Differentiation 21 (9), 1409-1418, 2014
342014
Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
GV Raj, GR Sareddy, S Ma, TK Lee, S Viswanadhapalli, R Li, X Liu, ...
Elife 6, e26857, 2017
322017
Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells
SR Krishnan, BC Nair, GR Sareddy, SS Roy, M Natarajan, T Suzuki, ...
Breast cancer research and treatment 150 (3), 487-499, 2015
222015
Inhibition of mTOR signaling reduces PELP1-mediated tumor growth and therapy resistance
VK Gonugunta, GR Sareddy, SR Krishnan, V Cortez, SS Roy, RR Tekmal, ...
Molecular cancer therapeutics 13 (6), 1578-1588, 2014
182014
Emerging significance of estrogen cancer coregulator signaling in breast cancer.
M Mann, S Krishnan, RK Vadlamudi
Minerva ginecologica 64 (1), 75-88, 2012
132012
Nanotherapeutics in cancer prevention, diagnosis and treatment
SR Krishnan, SK George
Pharmacology and Therapeutics; BoD—Books on Demand: Norderstedt, Germany, 233, 2014
122014
PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling
GR Sareddy, UP Pratap, S Viswanadhapalli, PP Venkata, BC Nair, ...
Neuro-oncology advances 1 (1), vdz042, 2019
42019
Therapeutic efficacy of ERβ agonists on ovarian cancer
GR Sareddy, JE Chavez, H Salazar, M Mann, J Hernandez, SR Krishnan, ...
Cancer Research 74 (19 Supplement), 606-606, 2014
22014
S-equol, an estrogen receptor β agonist, inhibits tumor growth and progression of breast cancer
C Samayoa, NK Krishnegowda, SR Krishnan, RK Vadlamudi, RR Tekmal
Cancer Research 74 (19 Supplement), 622-622, 2014
12014
Targeting of PELP1 in cancer therapy
RK Vadlamudi, M Monica, S Krishnan, GR Sareddy
US Patent 10,682,388, 2020
2020
Neuro-Oncology Advances
GR Sareddy, UP Pratap, S Viswanadhapalli, PP Venkata, BC Nair, ...
2019
ESR1 coregulator binding inhibitor (ECBI): a novel agent for treating hormone therapy-resistant breast cancer
RK Vadlamudi, GR Sareddy, S Viswanadhapalli, TK Lee, SH Ma, WR Lee, ...
Cancer Research 76 (14 Supplement), 860-860, 2016
2016
ESR1 coregulator binding inhibitor (ECBI) as a novel therapeutic to target hormone therapy resistant metastatic breast cancer
RK Vadlamudi, GR Sareddy, S Viswanadhapalli, TK Lee, SH Ma, WR Lee, ...
CANCER RESEARCH 76, 2016
2016
Abstract S3-04: ESR1 coregulator binding inhibitor (ECBI) as a novel therapeutic to target hormone therapy resistant metastatic breast cancer
RK Vadlamudi, GR Sareddy, S Viswanadhapalli, TK Lee, SH Ma, WR Lee, ...
Cancer Research 76 (4 Supplement), S3-04-S3-04, 2016
2016
Abstract B08: ESR1 coregulator binding site inhibitors (ECBIs) as novel therapeutics to target hormone therapy-resistant breast cancer
RK Vadlamudi, GR Sareddy, S Viswanadhapalli, TK Lee, SH Ma, WR Lee, ...
Molecular Cancer Research 14 (2 Supplement), B08-B08, 2016
2016
Targeting error-prone alternative nonhomologous end joining (A-NHEJ) DNA repair pathway to treat ESR1-mediated therapy resistance
S Krishnan, B Nair, G Sareddy, M Mann, RK Vadlamudi
Cancer Research 75 (15 Supplement), 2854-2854, 2015
2015
PELP1 promotes DNA double-strand break repair via alternative-NHEJ: Implications in therapy resistance
SR Krishnan, BC Nair, GR Sareddy, M Mann, RK Vadlamudi
Cancer Research 74 (19 Supplement), 2731-2731, 2014
2014
Novel role of proto-oncogene PELP1 in A-NHEJ pathway of double strand break repair: Implications for treatment of hormonal therapy resistance
SR Krishnan, BC Nair, M Mann, GR Saareddy, J Stark, V Gorbunova, ...
CANCER RESEARCH 73, 2013
2013
Abstract P5-09-12: Novel role of proto-oncogene PELP1 in A-NHEJ pathway of double strand break repair: Implications for treatment of hormonal therapy resistance
SR Krishnan, BC Nair, M Mann, GR Saareddy, J Stark, V Gorbunova, ...
Cancer Research 73 (24 Supplement), P5-09-12-P5-09-12, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20